U.S. Bancorp Operating Cash Flow decreased by 52.8% to $1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 535.1%, from -$308.00M to $1.34B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -5.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.58B | $2.65B | $703.00M | $8.48B | $2.25B | $3.51B | $6.89B | $842.00M | $3.32B | $3.87B | $362.00M | $2.66B | $2.87B | $972.00M | $4.84B | -$308.00M | $2.05B | $3.39B | $2.84B | $1.34B |
| QoQ Change | — | -52.6% | -73.4% | >999% | -73.5% | +55.8% | +96.5% | -87.8% | +293.8% | +16.8% | -90.7% | +635.1% | +8.0% | -66.2% | +398.3% | -106.4% | +766.9% | +64.9% | -16.3% | -52.8% |
| YoY Change | — | — | — | — | -59.7% | +32.4% | +879.8% | -90.1% | +47.4% | +10.5% | -94.7% | +216.0% | -13.3% | -74.9% | >999% | -111.6% | -28.5% | +248.6% | -41.4% | +535.1% |